Frankfurt - Delayed Quote EUR
Gossamer Bio, Inc. (4GB.F)
0.7475
+0.0580
+(8.41%)
As of 9:59:01 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ARANDA RICHARD Officer | Sale | Jun 24, 2024 | 199,430 |
| CHRISTIAN WAAGE Officer | Sale | Mar 27, 2024 | 654,048 |
| GIRAUDO BRYAN M. Chief Operating Officer | Purchase | Jun 18, 2024 | -- |
| HASNAIN FAHEEM Chief Executive Officer | Sale | Mar 27, 2024 | 5,156,370 |
| MILLIGAN SANDRA Director | Purchase | Nov 15, 2023 | -- |
| PETERSON CARYN Officer | Sale | Mar 18, 2024 | 49,833 |
| SMITH ROBERT PAUL JR Officer | Purchase | Jun 17, 2024 | -- |
Related Tickers
AAGH America Great Health
0.0050
0.00%
SANN.SW Santhera Pharmaceuticals Holding AG
14.30
-1.65%
ASMB Assembly Biosciences, Inc.
10.68
+2.61%
GLYC GlycoMimetics, Inc.
0.2521
+5.61%
TARA Protara Therapeutics, Inc.
4.2309
+0.73%
SKYE Skye Bioscience, Inc.
1.6699
-3.47%
MREO Mereo BioPharma Group plc
2.5400
-0.79%
TLSA Tiziana Life Sciences Ltd
1.3100
0.00%
STRO Sutro Biopharma, Inc.
0.8679
-3.57%
SLS SELLAS Life Sciences Group, Inc.
1.3200
+0.76%